Literature DB >> 25887613

Host factors that contribute to recurrent staphylococcal skin infection.

Christopher P Montgomery1, Michael Z David, Robert S Daum.   

Abstract

PURPOSE OF REVIEW: Staphylococcus aureus is the most common cause of skin and soft tissue infections (SSTI) in the United States and elsewhere. Recurrent infections occur frequently in patients with S. aureus SSTI, underscoring the need to better understand the nature of protective immunity against these infections. Here, we review recent findings concerning the host factors that predispose to S. aureus SSTI. RECENT
FINDINGS: Recurrent infections occur in nearly half of all patients with S. aureus SSTI. Epidemiologic and environmental factors, such as exposure to healthcare, age, and household contacts with S. aureus SSTI, and contaminated household fomites are associated with recurrence. The majority of the population has evidence of antistaphylococcal antibodies, but whether these are protective remains enigmatic. In contrast, recent clinical and experimental findings clearly highlight the critical roles of innate and T cell-mediated immunity in defense against these infections. S. aureus interferes with innate and adaptive immunity by a number of recently elucidated mechanisms.
SUMMARY: Recurrent S. aureus SSTIs are common, suggesting incomplete or absent protective immunity among these patients. Our understanding of protective immunity against recurrent infections is incomplete, and further basic and translational investigation is urgently needed to design strategies to prevent and treat these infections.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25887613      PMCID: PMC4414914          DOI: 10.1097/QCO.0000000000000156

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  46 in total

1.  The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.

Authors:  András N Spaan; Thomas Henry; Willemien J M van Rooijen; Magali Perret; Cédric Badiou; Piet C Aerts; Johan Kemmink; Carla J C de Haas; Kok P M van Kessel; François Vandenesch; Gérard Lina; Jos A G van Strijp
Journal:  Cell Host Microbe       Date:  2013-05-15       Impact factor: 21.023

Review 2.  Progress toward a Staphylococcus aureus vaccine.

Authors:  Robert S Daum; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2011-12-20       Impact factor: 9.079

3.  Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors.

Authors:  Loren G Miller; Samantha J Eells; Michael Z David; Nancy Ortiz; Alexis R Taylor; Neha Kumar; Denise Cruz; Susan Boyle-Vavra; Robert S Daum
Journal:  Clin Infect Dis       Date:  2014-11-26       Impact factor: 9.079

4.  Epicutaneous model of community-acquired Staphylococcus aureus skin infections.

Authors:  Ranjani Prabhakara; Oded Foreman; Roberto De Pascalis; Gloria M Lee; Roger D Plaut; Stanley Y Kim; Scott Stibitz; Karen L Elkins; Tod J Merkel
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

5.  Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus.

Authors:  G Thomas Ray; Jose A Suaya; Roger Baxter
Journal:  Diagn Microbiol Infect Dis       Date:  2013-03-26       Impact factor: 2.803

6.  A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.

Authors:  Stephanie A Fritz; Kristin M Tiemann; Patrick G Hogan; Emma K Epplin; Marcela Rodriguez; Duha N Al-Zubeidi; Juliane Bubeck Wardenburg; David A Hunstad
Journal:  Clin Infect Dis       Date:  2013-02-27       Impact factor: 9.079

7.  Recurrent community-associated Staphylococcus aureus infections in children presenting to Texas Children's Hospital in Houston, Texas.

Authors:  Claire E Bocchini; Edward O Mason; Kristina G Hulten; Wendy A Hammerman; Sheldon L Kaplan
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

8.  Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection.

Authors:  Tamara Reyes-Robles; Francis Alonzo; Lina Kozhaya; D Borden Lacy; Derya Unutmaz; Victor J Torres
Journal:  Cell Host Microbe       Date:  2013-10-16       Impact factor: 21.023

9.  Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection.

Authors:  Arby Abtin; Rohit Jain; Andrew J Mitchell; Ben Roediger; Anthony J Brzoska; Shweta Tikoo; Qiang Cheng; Lai Guan Ng; Lois L Cavanagh; Ulrich H von Andrian; Michael J Hickey; Neville Firth; Wolfgang Weninger
Journal:  Nat Immunol       Date:  2013-11-24       Impact factor: 25.606

10.  CCR5 is a receptor for Staphylococcus aureus leukotoxin ED.

Authors:  Francis Alonzo; Lina Kozhaya; Stephen A Rawlings; Tamara Reyes-Robles; Ashley L DuMont; David G Myszka; Nathaniel R Landau; Derya Unutmaz; Victor J Torres
Journal:  Nature       Date:  2012-12-12       Impact factor: 49.962

View more
  21 in total

1.  Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection.

Authors:  Carly A Dillen; Bret L Pinsker; Alina I Marusina; Alexander A Merleev; Orly N Farber; Haiyun Liu; Nathan K Archer; Da B Lee; Yu Wang; Roger V Ortines; Steven K Lee; Mark C Marchitto; Shuting S Cai; Alyssa G Ashbaugh; Larissa S May; Steven M Holland; Alexandra F Freeman; Loren G Miller; Michael R Yeaman; Scott I Simon; Joshua D Milner; Emanual Maverakis; Lloyd S Miller
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

2.  Staphylococcus aureus toxin suppresses antigen-specific T cell responses.

Authors:  Brandon Lee; Reuben Olaniyi; Jakub M Kwiecinski; Juliane Bubeck Wardenburg
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 3.  Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?

Authors:  Georgia R Sampedro; Juliane Bubeck Wardenburg
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

Review 4.  Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.

Authors:  Sarah E Rowe; Jenna E Beam; Brian P Conlon
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

5.  Killing of Staphylococcus aureus via Magnetic Hyperthermia Mediated by Magnetotactic Bacteria.

Authors:  Changyou Chen; Linjie Chen; Yong Yi; Chuanfang Chen; Long-Fei Wu; Tao Song
Journal:  Appl Environ Microbiol       Date:  2016-02-12       Impact factor: 4.792

Review 6.  Staphylococcus aureus pathogenesis in diverse host environments.

Authors:  Divya Balasubramanian; Lamia Harper; Bo Shopsin; Victor J Torres
Journal:  Pathog Dis       Date:  2017-01-01       Impact factor: 3.166

7.  Revisiting Bacterial Interference in the Age of Methicillin-resistant Staphylococcus aureus: Insights Into Staphylococcus aureus Carriage, Pathogenicity and Potential Control.

Authors:  Paul J Planet; Dane Parker; Naomi L Ruff; Henry R Shinefield
Journal:  Pediatr Infect Dis J       Date:  2019-09       Impact factor: 2.129

8.  Bacteriological analysis of selected phenotypes of chronic rhinosinusitis with co-existing asthma, allergy and hypersensitivity to non-steroidal anti-inflammatory drugs.

Authors:  Grażyna Stryjewska-Makuch; Małgorzata A Janik; Hanna Klamińska-Cebula; Bogdan Kolebacz; Wojciech Ścierski; Grażyna Lisowska
Journal:  Postepy Dermatol Alergol       Date:  2021-03-10       Impact factor: 1.837

9.  Intrahost Evolution of Methicillin-Resistant Staphylococcus aureus USA300 Among Individuals With Reoccurring Skin and Soft-Tissue Infections.

Authors:  Taj Azarian; Robert S Daum; Lindsay A Petty; Jenny L Steinbeck; Zachary Yin; David Nolan; Susan Boyle-Vavra; W P Hanage; Marco Salemi; Michael Z David
Journal:  J Infect Dis       Date:  2016-06-10       Impact factor: 5.226

10.  Adoptive Transfer of Serum Samples From Children With Invasive Staphylococcal Infection and Protection Against Staphylococcus aureus Sepsis.

Authors:  Chih-Ming Tsai; Nicole Soper; Monique Bennett; Jonathan K Fallon; Ashlin R Michell; Galit Alter; George Y Liu; Isaac Thomsen
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.